Delaware SUPPORT Office Based Opioid Treatment (OBOT) Fellowship - Clinical Provider Track: August 11, 2021

August 11, 2021

Jointly Provided by the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) and the American Institutes for Research (AIR).

ELEMENTS OF COMPETENCE

This CE activity has been designed to improve learner competence and performance and focuses on the American Board of Medical Specialties’ areas of patient care and procedural skills and medical knowledge.

This activity focuses on the Interprofessional competencies of roles/responsibilities, interprofessional communication, and teams/teamwork.

This activity also focuses on the Institute of Medicine competencies of provide patient-centered care, work in interdisciplinary teams and employ evidence-based practice.

Target Audience

This program is intended for clinicians on identification, diagnosis and treatment of opioid use disorder.

Learning Objectives

At the conclusion of the activity, the clinical healthcare team members will be able to:

  1. Differentiate substance use and misuse from other use disorder based on DSM-5 diagnostic criteria
  2. Review treatment strategies for non-opioid substance use disorders and determine how to integrate these into treatment strategies for OUD
  3. Discuss interventions including Brief Interventions for other substance use
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 ANCC Contact Hours
  • 1.00 University of Wisconsin–Madison Continuing Education Hours
    • 1.00 Approved for AMA PRA Category 1 Credit™
Registration opens: 
04/01/2021
Course expires: 
10/31/2021
Event starts: 
08/11/2021 - 4:00pm CDT
Event ends: 
08/11/2021 - 5:00pm CDT
Cost:
$0.00
Rating: 
0

POLICY ON DISCLOSURE

It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) that the faculty, authors, planners, and other persons who may influence content of this CE activity disclose all relevant financial relationships with commercial interests* in order to allow CE staff to identify and resolve any potential conflicts of interest.  Faculty must also disclose any planned discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s). 

For this educational activity, all conflicts of interest have been resolved and detailed disclosures are listed below:

Name

Role

Financial Relationship Disclosures

Discussion of Unlabeled/
Unapproved uses of drugs/
devices in presentation?

Maliha Ali, MBBS, DrPH

Committee Member

No relevant financial relationships to disclose

No

Anika Alvanzo, MD

Speaker/Author

American Society of Addiction Medicine (Fiduciary Officer), Maryland Department of Health and Mental Hygiene (Contractor); Pyramid Healthcare, Inc. (Employment)

No

Terese Bailey, BS

Planner

No relevant financial relationships to disclose

No

Kathryn Basques, MSW, MSN, APN, PMHMP-BC

Speaker/Author

No relevant financial relationships to disclose

Yes

Amanda Brooks, LCSW, CADC

Speaker/Author

No relevant financial relationships to disclose

No

Megan Buresh, MD

Speaker/Author

American Society of Addiction Medicine (Contractor)

No

Quy Nhi Cap, MPH

Committee Member & Planner

No relevant financial relationships to disclose

No

Nicole Gastala, MD

Speaker/Author

No relevant financial relationships to disclose

No

Daniel Harwell, MS

Committee Member

No relevant financial relationships to disclose

No

Terry Horton, MD, FACP, DABAM

Speaker/Author

Masimo (Consultant and Advisory Group Member)

No

Sarah Mossburg, BSN, MS, PhD

Committee Member

No relevant financial relationships to disclose

No

Elizabeth Salsbury-Afshar, MD, MPH, FAAFP, FACPM, DFASAM

Committee Member, Speaker/Author, Content Reviewer

No relevant financial relationships to disclose

No

Mishka Terplan, MD, MPH, FACOG, DFASAM

Committee Member, Speaker/Author, Content Reviewer

No relevant financial relationships to disclose

No

Claire Viscione, BS

Committee Member

No relevant financial relationships to disclose

No

Krishna Winfrey, BS

Committee Member

No relevant financial relationships to disclose

No

*The ACCME defines a commercial interest as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests.

Discloser List CME Internal Report
In support of improving patient care, this activity has been planned and implemented by the University of Wisconsin–Madison ICEP and American Institutes on Research (AIR). The University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

American Medical Association (AMA)

The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Nurses Credentialing Center (ANCC)

The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1.0 ANCC contact hours.

Continuing Education Units (CEUs)

The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 0.1 CEUs or 1.0 hour.

 

Available Credit

  • 1.00 AMA PRA Category 1 Credit
  • 1.00 ANCC Contact Hours
  • 1.00 University of Wisconsin–Madison Continuing Education Hours
    • 1.00 Approved for AMA PRA Category 1 Credit™

Price

Cost:
$0.00
Please login or register to take this course.